Key facts
- It has raised $1.4M; the latest was Seed Round ($1.4M) in Sep 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Shanghai Guoyutang Pharmaceutical Technology Development
- ·The full record, as it builds
Funding rounds
No funding rounds for Shanghai Guoyutang Pharmaceutical Technology Development are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shanghai Guoyutang Pharmaceutical Technology Development
Manufacturer of a pharmaceutical technology product, intended to develop breakthrough pharmaceutical drugs and inventive medical devices that address pressing health-care needs. The company offers strong technical research capabilities, medical device innovation, and a deep understanding of unmet clinical demands, enabling healthcare institutions and patients access to novel medical technologies that improve treatment outcomes and fill gaps in current therapeutic options.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Shanghai Guoyutang Pharmaceutical Technology Development doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shanghai Guoyutang Pharmaceutical Technology Development shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shanghai Guoyutang Pharmaceutical Technology Development in its N-PORT filings yet. We sweep new filings monthly.